
PainReform Ltd. PRFX
$ 3.21
-7.76%
Annual report 2023
added 02-15-2025
Country |
![]() |
IPO year |
2020 |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
Dr. Ehud Geller Ph.D. |
Employees in the company |
- |
Shares |
1.31 M |
Market Cap[1] |
$ 4.2 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.